Senti Bio (SNTI) Debuts as Publicly Traded Company

June 9, 2022 7:33 AM UTC Send to a Friend
Senti Biosciences, Inc. (“Senti Bio”), a biotechnology company developing next-generation cell and gene therapies using its proprietary gene circuit platform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login